Mucoepidermoid carcinoma is a rare conjunctival neoplasm1 that is a common malignancy in the salivary glands.2,3 In the conjunctiva it often mimics squamous cell carcinoma.3 Histologically the tumors are believed to arise from pluripotential basal cells and, possibly, mucus-secreting elements, and therefore are composed of mucus-secreting cells intermixed with epidermoid cells.1
The clear cell variant of mucoepidermoid carcinoma has been described in the major and minor salivary glands, the oral cavity, the skin, and the upper respiratory tract.4- 6 We report a case of a clear cell variant of mucoepidermoid carcinoma of the conjunctiva. To our knowledge, this variant has not been previously reported in the conjunctiva.
A 65-year-old Hispanic man was first seen by us with a 2-month history of a large, multilobulated conjunctival tumor on the lateral epibulbar surface of the left eye. His ocular history was unremarkable. His medical history was pertinent for uncontrolled diabetes mellitus for 5 years and “fluid removal from the right lung” within the past year.
On examination, his best-corrected visual acuity was 20/50 OU and his intraocular pressure was 11 mm Hg OD and 18 mm Hg OS. External examination showed a large temporal mass without adenopathy. In the left eye, an elevated mass with a multilobular surface, measuring 15.0 × 15.0 × 8.. mm, extended from the lateral canthus to the cornea (figure 1). The remaining superior bulbar conjunctiva was unremarkable, and no masses were seen on the lid or in the fornix. No orbital masses were palpable. The remaining anterior segment examination was unremarkable except for mild nuclear sclerosis. Gonioscopy demonstrated an open anterior chamber angle.
figure 1. Large, fleshy, vascularized, multilobulated mass on the temporal bulbar conjunctiva extending onto the peripheral cornea.
An incisional biopsy was performed in an attempt to debulk the mass, and cryotherapy was applied to the margins. Extensive bleeding occurred during the procedure, and it was difficult to dissect the mass to the posterior extent of the lesion.
Histopathologic examination of the conjunctival tissue revealed a large, multilobular tumor in the substantia propria that focally infiltrated the superficial epithelium. The epithelium was acanthotic in the areas of tumor invasion and replaced by clear tumor cells (figure 2). In the substantia propria, the tumor lobules were composed of a mixture of clear cells and areas of squamous differentiation (Figure 2 and figure 3). The clear cells exhibited large, hyperchromatic, highly pleomorphic nuclei. Frequent mitotic figures were seen (figure 4). Squamous cells with hyperchromatic nuclei and eosinophilic cytoplasm were observed focally. The clear cells showed intracytoplasmic periodic acid–Schiff–positive granules that were sensitive to diastase (figure 5). Rare clear cells deep within the substantia propria showed positive staining with mucicarmine (figure 6. and Alcian blue, indicating the presence of mucus-secreting cells. Immunohistochemical studies showed no staining of the tumor cells for S100 protein. The tumor extended to the margin of the resection.
figure 2. Acanthotic surface epithelium infiltrated by clear cells mimicking “pagetoid” spread. Note tumor infiltration into the stroma (hematoxylin-eosin, original magnification ×5).
figure 3. Photomicrograph of conjunctiva showing lobules of clear cells (asterisk) with islands of squamous cells (arrows) (hematoxylin-eosin, original magnification ×2.5).
figure 4. Clear cells at higher magnification showing marked nuclear pleomorphism and mitotic figures (arrow). Occasional cells with bizarre nuclei and abundant eosinophilic cytoplasm are present (hematoxylin-eosin, original magnification ×20).
figure 5. Intracytoplasmic periodic acid–Schiff–positive granules (A) that are diastase sensitive (B) are present within the clear cells (original magnification ×20).
Figure 6. Photomicrograph showing mucus-producing cells (arrows) within the tumor (mucicarmine, original magnification ×40).
The patient subsequently underwent exenteration of the left orbit. Further investigation revealed emphysema, enlarged mediastinal lymph nodes, and an area of pleural thickening. Other clinical and radiologic details of his follow-up and the pathological diagnosis of the mediastinal lymph nodes were not available.
This case highlights the clinical and histologic findings of an unusual variant of mucoepidermoid carcinoma—the clear cell variant in the conjunctiva. The most common clinical presentation of mucoepidermoid carcinoma in the conjunctiva is a limbal/perilimbal mass that is usually interpalpebral, similar to squamous cell carcinoma of the conjunctiva.3
The abundance of clear cells in this tumor made it a diagnostic challenge. Clear cells in mucoepidermoid carcinoma of the salivary glands (where this neoplasm is more frequently seen) are not uncommon and may constitute up to 10% of the cell population.2 However, even in the salivary glands the predominance of clear cells in mucoepidermoid carcinoma is unusual.2 It is only through identification of mucoid and epidermoid components with an abundance of periodic acid–Schiff–positive, diastase-sensitive clear cells that a diagnosis of mucoepidermoid carcinoma–clear cell variant was reached in our patient.
The grading of mucoepidermoid carcinoma is dependent on the number of mitotic figures, nuclear pleomorphism, perineural invasion, necrosis, and solid vs cystic morphologic characteristics and not on the proportion of cell types.2 Although the presence of clear cells does not affect the grading of mucoepidermoid carcinoma, it has been noted that clear cells usually predominate in high-grade tumors.7 The origin of these clear cells in mucoepidermoid carcinoma has been debated. They may be a result of hydropic degeneration of the epidermoid cells, but may also result from fixation artifacts, sparse organelles, or the presence of mucin, glycogen, or lipid.2,4
The other unusual feature of this tumor was the infiltration of the superficial epithelium by the neoplastic cells, akin to a “pagetoid growth pattern.” The apparent pagetoid change and the presence of clear cells made it difficult to differentiate this tumor from sebaceous cell carcinoma. However, sebaceous carcinoma cells do not exhibit the abundant periodic acid–Schiff–positive granules in the cytoplasm and, instead, stain positive with lipid stains.8
Apart from sebaceous cell carcinoma, the differential diagnosis of clear cell carcinomas in the conjunctiva includes balloon cell melanoma. The lack of intracytoplasmic melanin pigment and S100 protein immunostaining made balloon cell melanoma unlikely. The differential diagnosis may also include clear cell oncocytoma, eccrine acrospiroma, acinic cell adenocarcinoma, and metastatic carcinomas from the thyroid, kidney, or lung.2,4,6 In our patient, metastatic clear cell carcinoma from the lung was considered, but histologic sections showing transitional areas that included squamous and mucus-secreting cells suggested that the tumor was conjunctival in origin.
In the conjunctiva, mucoepidermoid carcinomas are aggressive tumors that are locally and regionally invasive.3,9 Recurrence rates after excision are almost 100%.3 Therefore, early diagnosis is essential. Lymph node involvement has been described, but distant metastasis is unusual if the tumor is treated aggressively.9 The clear cell variant in the conjunctiva may prove to be more aggressive. The treatment includes wide excision, adjuvant cryotherapy, and enucleation/exenteration in addition to radiotherapy for recurrent lesions.9,10
Correspondence: Dr Edward, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, 185. W Taylor St, M/C 648, Chicago, IL 60612 (email@example.com).
Financial Disclosure: None.
Funding/Support: This study was supported in part by a National Eye Institute Core Grant for Vision Research (EY01792), Bethesda, Md, and an unrestricted grant from Research to Prevent Blindness, Inc, New York, NY.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Ophthalmology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.